Diffuse parenchymal lung disease
Between September 2015 and August 2016 there were >1500 publications in the field of diffuse parenchymal lung diseases (DPLDs). For the Clinical Year in Review session at the European Respiratory Society Congress that was held…
err.ersjournals.com
Alveolar stem cell failure implicated in pulmonary fibrosis
The failure of type 2 alveolar epithelial cells appears to be a major cause of pulmonary fibrosis, according to a report published online in Nature Medicine.
mdedge.com
Riociguat shows benefit in PAH with poor response to PDE inhibitors
LOS ANGELES – Pulmonary artery hypertension patients who have an insufficient response to phosphodiesterase inhibitors may benefit from a switch to riociguat (Adempas), based on results from a…
mdedge.com